Reply to ‘Comment on: Long-term outcomes of neovascular glaucoma treated with and without intravitreal bevacizumab’ – (Eye 30, 897 (June 2016))
Reply to ‘Comment on: Long-term outcomes of neovascular glaucoma treated with and without intravitreal bevacizumab’ Eye 30, 897 (June 2016). doi:10.1038/eye.2016.32 Authors: L C Olmos, M S Sayed & R K Lee
Comment on: ‘Effectiveness of a smartphone application for testing near-visual acuity’ – (Eye 30, 898 (June 2016))
Comment on: ‘Effectiveness of a smartphone application for testing near-visual acuity’ Eye 30, 898 (June 2016). doi:10.1038/eye.2016.35 Author: M Rodríguez-Vallejo
Comment on: ‘Effectiveness of a smartphone application for testing near visual acuity’ – (Eye 30, 899 (June 2016))
Comment on: ‘Effectiveness of a smartphone application for testing near visual acuity’ Eye 30, 899 (June 2016). doi:10.1038/eye.2016.36 Authors: I T Hossain, H H Malik & M Franka
Comment on ‘The Royal College of Ophthalmologists Guidelines on retinal vein occlusions: executive summary’ – (Eye 30, 771 (June 2016))
Comment on ‘The Royal College of Ophthalmologists Guidelines on retinal vein occlusions: executive summary’ Eye 30, 771 (June 2016). doi:10.1038/eye.2016.63 Author: S S Hayreh
Introduction to metabolomics and its applications in ophthalmology – (Eye 30, 773 (June 2016))
Introduction to metabolomics and its applications in ophthalmology Eye 30, 773 (June 2016). doi:10.1038/eye.2016.37 Authors: S Z Tan, P Begley, G Mullard, K A Hollywood & P N Bishop